DB-036

N/A

Report date: 2025/06/20 20:01:04

Base Information

Drug NameDB-036
Drug Alias NameAAV gene therapy (Digna Biotech)AAV-IGF-1DB-036
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionInsulin-like growth factor I stimulants
TargetsInsulin-like growth factor I
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDigna Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDigna Biotech Sl
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A